Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
LIONVILLE, Pa., Feb. 22 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE:WST) today announced that its Board of Directors has approved payment of the second-quarter 2010 cash...
LIONVILLE, Pa., Jan. 20 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE:WST) today announced William Federici, Chief Financial Officer and Michael A. Anderson, Vice President...
LIONVILLE, Pa., Jan. 7 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE:WST) today announced that Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, and William...
- Reports $0.50 per Diluted Share, $0.45 per Diluted Share Excluding Unusual Items - - Revises 2009 Adjusted Diluted EPS(1) Estimate to between $2.08 and $2.13 - - Announces Fourth Quarter...
LIONVILLE, Pa., Oct. 27 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release 2009 third quarter financial results before the market opens...
LIONVILLE, Pa., Sept. 11 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE:WST) today announced that Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, and...
Could not retrieve article
LIONVILLE, Pa., July 7 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE:WST) today announced that it has purchased the drug delivery device business assets of Plastef...
RNS Number:4317T Westside Acquisitions PLC 18 December 2003 Westside Acquisitions plc ("the Company") Purchase of Own Shares Pursuant to its share buy-back authority, the Company...
RNS Number:3500Q Westside Acquisitions PLC 30 September 2003 WESTSIDE ACQUISITIONS PLC ("Westside" or "the Company" or "the Group") Interim results for the six months ended 30 June...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
